Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Open Access
- 6 December 2024
- journal article
- research article
- Published by Springer Nature in npj Regenerative Medicine
- Vol. 9 (1) , 1-11
Abstract
Cutaneous exposure to the DNA alkylating class of chemotherapeutic agents including nitrogen mustard (NM) leads to both skin injury and systemic inflammation. Circulating myeloid subsets recruited to the skin act to further exacerbate local tissue damage while interfering with the wound healing process. We demonstrate herein that intravenous delivery of poly(lactic-co-glycolic acid) immune-modifying nanoparticles (PLGA-IMPs) shortly after NM exposure restricts accumulation of macrophages and inflammatory monocytes at the injury site, resulting in attenuated skin pathology. Furthermore, PLGA-IMPs induce an early influx and local enrichment of Foxp3+ regulatory T cells (Treg) in the skin lesions critical for the suppression of myeloid cell-pro-inflammatory responses via induction of IL-10 and TGF-β in the cutaneous milieu. Functional depletion of CD4+ Tregs ablates the efficacy of PLGA-IMPs accompanied by a loss of local accumulation of anti-inflammatory cytokines essential for wound healing. Thus, in severe skin trauma, PLGA-IMPs may have therapeutic potential via modulation of inflammatory myeloid cells and regulatory T lymphocytes.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR0797905, P30 AR075049, U01 AR071168, U54 AR0797905, U54 AR0797905, U54 AR0797905, U54 AR0797905, U54 AR0797905, U54 AR0797905, U54 AR0797905, U54 AR0797905, U54 AR0797905, U54 AR0797905)
This publication has 35 references indexed in Scilit:
- Antioxidant/stress response in mouse epidermis following exposure to nitrogen mustardExperimental and Molecular Pathology, 2020
- Intravenous Immunomodulatory Nanoparticle Treatment for Traumatic Brain InjuryAnnals of Neurology, 2020
- Expression of cytokines and chemokines in mouse skin treated with sulfur mustardToxicology and Applied Pharmacology, 2018
- Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectivesEuropean Journal of Medicinal Chemistry, 2018
- Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in miceNeurobiology of Disease, 2017
- Suppression of Hyperactive Immune Responses Protects against Nitrogen Mustard InjuryJournal of Investigative Dermatology, 2015
- Distinct Murine Mucosal Langerhans Cell Subsets Develop from Pre-dendritic Cells and MonocytesImmunity, 2015
- Topical Chemotherapy in Cutaneous T-cell LymphomaJAMA Dermatology, 2013
- Antigen‐specific Treg regulate Th17‐mediated lung neutrophilic inflammation, B‐cell recruitment and polymeric IgA and IgM levels in the airwaysEuropean Journal of Immunology, 2009
- Chemical warfareJournal of the American Academy of Dermatology, 1988